A hereditary spastic paraplegia mutation in kinesin-1A/KIF5A disrupts neurofilament transport

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Wang, Lina ^a   Brown, Anthony ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KINESIN 1; PROTEIN; SPG10 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; MOUSE; NERVE FIBER TRANSPORT; NEUROFILAMENT; NONHUMAN; RETROGRADE NERVE FIBER TRANSPORT;

EID: 78349285209     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-52     Document Type: Article

References (61)

1. Hereditary spastic paraplegia. JK Fink, Curr Neurol Neurosci Rep 2006 6 1 65 76 10.1007/s11910-996-0011-1 16469273
2. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. S Salinas C Proukakis A Crosby TT Warner, Lancet Neurol 2008 7 12 1127 1138 10.1016/S1474-4422(08)70258-8 19007737
3. Kinesin superfamily motor proteins and intracellular transport. N Hirokawa Y Noda Y Tanaka S Niwa, Nat Rev Mol Cell Biol 2009 10 10 682 696 10.1038/nrm2774 19773780
4. Conventional kinesin holoenzymes are composed of heavy and light chain homodimers. SR DeBoer Y You A Szodorai A Kaminska G Pigino E Nwabuisi B Wang T Estrada-Hernandez S Kins ST Brady, et al. Biochemistry 2008 47 15 4535 4543 10.1021/bi702445j 18361505
5. Cloning and localization of a conventional kinesin motor expressed exclusively in neurons. J Niclas F Navone N Hom-Booher RD Vale, Neuron 1994 12 5 1059 1072 10.1016/0896-6273(94)90314-X 7514426
6. Cloning and expression of a human kinesin heavy chain gene: interaction of the COOH-terminal domain with cytoplasmic microtubules in transfected CV-1 cells. F Navone J Niclas N Hom-Booher L Sparks HD Bernstein G McCaffrey RD Vale, J Cell Biol 1992 117 6 1263 1275 10.1083/jcb.117.6.1263 1607388
7. Chromosomal localization reveals three kinesin heavy chain genes in mouse. C Xia A Rahman Z Yang LS Goldstein, Genomics 1998 52 2 209 213 10.1006/geno.1998.5427 9782088
8. Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. AE Twelvetrees EY Yuen IL Arancibia-Carcamo AF MacAskill P Rostaing MJ Lumb S Humbert A Triller F Saudou Z Yan, et al. Neuron 2010 65 1 53 65 10.1016/j.neuron.2009.12.007 20152113
9. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. S Taya T Shinoda D Tsuboi J Asaki K Nagai T Hikita S Kuroda K Kuroda M Shimizu S Hirotsune, et al. J Neurosci 2007 27 1 15 26 10.1523/JNEUROSCI.3826-06.2006 17202468
10. DISC1 regulates neurotrophin-induced axon elongation via interaction with Grb2. T Shinoda S Taya D Tsuboi T Hikita R Matsuzawa S Kuroda A Iwamatsu K Kaibuchi, J Neurosci 2007 27 1 4 14 10.1523/JNEUROSCI.3825-06.2007 17202467
11. Beta-dystrobrevin interacts directly with kinesin heavy chain in brain. P Macioce G Gambara M Bernassola L Gaddini P Torreri G Macchia C Ramoni M Ceccarini TC Petrucci, J Cell Sci 2003 116 Pt 23 4847 4856 10.1242/jcs.00805 14600269
12. Molecular basis of dystrobrevin interaction with kinesin heavy chain: structural determinants of their binding. M Ceccarini P Torreri DG Lombardi G Macchia P Macioce TC Petrucci, J Mol Biol 2005 354 4 872 882 10.1016/j.jmb.2005.09.069 16288919
13. Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. R Perrot R Berges A Bocquet J Eyer, Mol Neurobiol 2008 38 1 27 65 10.1007/s12035-008-8033-0 18649148
14. Rapid movement of axonal neurofilaments interrupted by prolonged pauses. L Wang C-L Ho D Sun RKH Liem A Brown, Nat Cell Biol 2000 2 3 137 141 10.1038/35004008 10707083
15. Stochastic simulation of neurofilament transport in axons: the "stop-and-go" hypothesis. A Brown L Wang P Jung, Mol Biol Cell 2005 16 9 4243 4255 10.1091/mbc.E05-02-0141 16000374
16. Neurofilaments switch between distinct mobile and stationary states during their transport along axons. N Trivedi P Jung A Brown, J Neurosci 2007 27 507 516 10.1523/JNEUROSCI.4227-06.2007 17234583
17. Modeling the slowing of neurofilament transport along the mouse sciatic nerve. P Jung A Brown, Phys Biol 2009 6 4 046002 10.1088/1478-3975/6/4/046002 19700813
18. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. CH Xia EA Roberts LS Her X Liu DS Williams DW Cleveland LS Goldstein, J Cell Biol 2003 161 1 55 66 10.1083/jcb.200301026 12682084
19. Tight functional coupling of kinesin-1A and dynein motors in the bidirectional transport of neurofilaments. A Uchida NH Alami A Brown, Mol Biol Cell 2009 20 23 4997 5006 10.1091/mbc.E09-04-0304 19812246
20. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). E Reid M Kloos A Ashley-Koch L Hughes S Bevan IK Svenson FL Graham PC Gaskell A Dearlove MA Pericak-Vance, et al. Am J Hum Genet 2002 71 5 1189 1194 10.1086/344210 12355402
21. Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. M Fichera M Lo Giudice M Falco M Sturnio S Amata O Calabrese S Bigoni E Calzolari M Neri, Neurology 2004 63 6 1108 1110 15452312
22. Mutation in KIF5A can also cause adult-onset hereditary spastic paraplegia. MA Blair S Ma P Hedera, Neurogenetics 2006 7 1 47 50 10.1007/s10048-005-0027-8 16489470
23. A missense mutation in the coiled-coil domain of the KIF5A gene and late-onset hereditary spastic paraplegia. M Lo Giudice M Neri M Falco M Sturnio E Calzolari D Di Benedetto M Fichera, Arch Neurol 2006 63 2 284 287 10.1001/archneur.63.2.284 16476820
24. SPG10 is a rare cause of spastic paraplegia in European families. R Schule BP Kremer J Kassubek M Auer-Grumbach VS Kostic T Klopstock S Klimpe S Otto S Bosch BP van de Warrenburg, et al. J Neurol Neurosurg Psychiatry 2008 79 5 584 587 10.1136/jnnp.2007.137596 18245137
25. A novel KIF5A/SPG10 mutation in spastic paraplegia associated with axonal neuropathy. A Tessa G Silvestri MF de Leva A Modoni PS Denora M Masciullo MT Dotti C Casali MA Melone A Federico, et al. J Neurol 2008 255 7 1090 1092 10.1007/s00415-008-0840-8 18500496
26. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. C Goizet A Boukhris E Mundwiller C Tallaksen S Forlani A Toutain N Carriere V Paquis C Depienne A Durr, et al. Hum Mutat 2009 30 2 376 385 10.1002/humu.20920 18853458
27. Arrival, reversal and departure of neurofilaments at the tips of growing axons. A Uchida A Brown, Mol Biol Cell 2004 15 4215 4225 10.1091/mbc.E04-05-0371 15215317
28. Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. JV Shah LA Flanagan PA Janmey J-F Leterrier, Mol Biol Cell 2000 11 3495 3508 11029051
29. Rapid transport of neural intermediate filament protein. BT Helfand P Loomis M Yoon RD Goldman, J Cell Sci 2003 116 Pt 11 2345 2359 10.1242/jcs.00526 12711702
30. The interaction of neurofilaments with the microtubule motor cytoplasmic dynein. OI Wagner J Ascano M Tokito JF Leterrier PA Janmey EL Holzbaur, Mol Biol Cell 2004 15 11 5092 5100 10.1091/mbc.E04-05-0401 15342782 (Pubitemid 39392222)
31. Role of cytoplasmic dynein in the axonal transport of microtubules and neurofilaments. Y He F Francis KA Myers W Yu MM Black PW Baas, J Cell Biol 2005 168 5 697 703 10.1083/jcb.200407191 15728192
32. Microtubules grow and shorten at intrinsically variable rates. RF Gildersleeve AR Cross KE Cullen AP Fagen RC Williams Jr, J Biol Chem 1992 267 12 7995 8006 1569058
33. Bidirectional transport along microtubules. MA Welte, Curr Biol 2004 14 13 525 537 10.1016/j.cub.2004.06.045 15242636
34. Hither and yon: a review of bi-directional microtubule-based transport. SP Gross, Phys Biol 2004 1 1-2 1 11 10.1088/1478-3967/1/2/R01 16204815
35. Bidirectional transport by molecular motors: enhanced processivity and response to external forces. MJ Muller S Klumpp R Lipowsky, Biophys J 2010 98 11 2610 2618 10.1016/j.bpj.2010.02.037 20513405
36. Tug-of-war as a cooperative mechanism for bidirectional cargo transport by molecular motors. MJ Muller S Klumpp R Lipowsky, Proc Natl Acad Sci USA 2008 105 12 4609 4614 10.1073/pnas.0706825105 18347340
37. Decoupling of nucleotide- and microtubule-binding sites in a kinesin mutant. HB Song SA Endow, Nature 1998 396 6711 587 590 10.1038/25153 9859995
38. Loss of function of Saccharomyces cerevisiae kinesin-related CIN8 and KIP1 is suppressed by KAR3 motor domain mutations. MA Hoyt L He L Totis WS Saunders, Genetics 1993 135 1 35 44 8224825
39. Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. B Ebbing K Mann A Starosta J Jaud L Schols R Schule G Woehlke, Hum Mol Genet 2008 17 9 1245 1252 10.1093/hmg/ddn014 18203753
40. Neurofilaments and neurological disease. A Al-Chalabi CC Miller, Bioessays 2003 25 4 346 355 10.1002/bies.10251 12655642
41. Neuronal intermediate filaments and neurodegenerative disorders. R Perrot J Eyer, Brain Res Bull 2009 80 4-5 282 295 10.1016/j.brainresbull.2009.06.004 19539727
42. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. J-F Collard F Cté J-P Julien, Nature 1995 375 61 64 10.1038/375061a0 7536898
43. Role of axonal transport in neurodegenerative diseases. KJ De Vos AJ Grierson S Ackerley CC Miller, Annu Rev Neurosci 2008 31 151 173 10.1146/annurev.neuro.31.061307.090711 18558852
44. Axonal transport and neurodegenerative disease. E Chevalier-Larsen EL Holzbaur, Biochim Biophys Acta 2006 1762 11-12 1094 1108 16730956
45. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. B Zhang P Tu F Abtahian JQ Trojanowski VM Lee, J Cell Biol 1997 139 5 1307 1315 10.1083/jcb.139.5.1307 9382875
46. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. TL Williamson DW Cleveland, Nat Neurosci 1999 2 1 50 56 10.1038/4553 10195180
47. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. BH LaMonte KE Wallace BA Holloway SS Shelly J Ascano M Tokito T Van Winkle DS Howland EL Holzbaur, Neuron 2002 34 5 715 727 10.1016/S0896-6273(02)00696-7 12062019
48. Mutant dynactin in motor neuron disease. I Puls C Jonnakuty BH LaMonte EL Holzbaur M Tokito E Mann MK Floeter K Bidus D Drayna SJ Oh, et al. Nat Genet 2003 33 4 455 456 10.1038/ng1123 12627231
49. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. M Hafezparast R Klocke C Ruhrberg A Marquardt A Ahmad-Annuar S Bowen G Lalli AS Witherden H Hummerich S Nicholson, et al. Science 2003 300 5620 808 812 10.1126/science.1083129 12730604
50. A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. A Tarrade C Fassier S Courageot D Charvin J Vitte L Peris A Thorel E Mouisel N Fonknechten N Roblot, et al. Hum Mol Genet 2006 15 24 3544 3558 10.1093/hmg/ddl431 17101632
51. Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients. PR Kasher KJ De Vos SB Wharton C Manser EJ Bennett M Bingley JD Wood R Milner CJ McDermott CC Miller, et al. J Neurochem 2009 110 1 34 44 10.1111/j.1471-4159.2009.06104.x 19453301
52. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. F Cote JF Collard JP Julien, Cell 1993 73 1 35 46 10.1016/0092-8674(93)90158-M 8462101
53. Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport. JR Marszalek TL Williamson MK Lee ZS Xu PN Hoffman MW Becher TO Crawford DW Cleveland, J Cell Biol 1996 135 3 711 724 10.1083/jcb.135.3.711 8909545
54. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. TL Williamson LI Bruijn Q Zhu KL Anderson SD Anderson JP Julien DW Cleveland, Proc Natl Acad Sci USA 1998 95 16 9631 9636 10.1073/pnas.95.16.9631 9689132
55. Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS. CS Lobsiger ML Garcia CM Ward DW Cleveland, Proc Natl Acad Sci USA 2005 102 29 10351 10356 10.1073/pnas.0503862102 16002469
56. Pathogenesis of two axonopathies does not require axonal neurofilaments. J Eyer DW Cleveland PC Wong AC Peterson, Nature 1998 391 6667 584 587 10.1038/35378 9468135
57. Neurofilaments are nonessential to the pathogenesis of toxicant-induced axonal degeneration. JD Stone AP Peterson J Eyer TG Oblak DW Sickles, J Neurosci 2001 21 7 2278 2287 11264303
58. Distal axonopathy does not occur without neurofilament accumulation in gamma-diketone neuropathy: comparative studies of normal and neurofilament-deficient quail. T Hirai M Mizutani K Ochiai T Umemura C Itakura, Acta Neuropathol (Berl) 1999 97 6 552 556 10.1007/s004010051030 (Pubitemid 29231672)
59. The polypeptide composition of moving and stationary neurofilaments in cultured sympathetic neurons. Y Yan K Jensen A Brown, Cell Motil Cytoskel 2007 64 299 309 10.1002/cm.20184 (Pubitemid 46452038)
60. The microtubule plus-end tracking protein EB1 is required for Kv1 voltage-gated K+ channel axonal targeting. C Gu W Zhou MA Puthenveedu M Xu YN Jan LY Jan, Neuron 2006 52 5 803 816 10.1016/j.neuron.2006.10.022 17145502
61. Culturing hippocampal neurons. S Kaech G Banker, Nat Protoc 2006 1 5 2406 2415 10.1038/nprot.2006.356 17406484